471 related articles for article (PubMed ID: 31259484)
41. N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity.
Patton KK; Heckbert SR; Alonso A; Bahrami H; Lima JA; Burke G; Kronmal RA
Heart; 2013 Dec; 99(24):1832-6. PubMed ID: 24131775
[TBL] [Abstract][Full Text] [Related]
42. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
43. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
44. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.
Dixen U; Ravn L; Soeby-Rasmussen C; Paulsen AW; Parner J; Frandsen E; Jensen GB
Cardiology; 2007; 108(1):35-9. PubMed ID: 16968988
[TBL] [Abstract][Full Text] [Related]
45. Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.
Kneihsl M; Gattringer T; Bisping E; Scherr D; Raggam R; Mangge H; Enzinger C; Fandler-Höfler S; Eppinger S; Hermetter C; Bucnik B; Poltrum B; Niederkorn K; Fazekas F
Stroke; 2019 Aug; 50(8):2223-2226. PubMed ID: 31216968
[TBL] [Abstract][Full Text] [Related]
46. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
[TBL] [Abstract][Full Text] [Related]
47. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
[TBL] [Abstract][Full Text] [Related]
48. Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial).
Patel RB; Vaduganathan M; Felker GM; Butler J; Redfield MM; Shah SJ
Am J Cardiol; 2019 May; 123(10):1660-1666. PubMed ID: 30876658
[TBL] [Abstract][Full Text] [Related]
49. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
[TBL] [Abstract][Full Text] [Related]
50. NT-proBNP values in elderly heart failure patients with atrial fibrillation and diabetes.
Sitar Taut AV; Pop D; Zdrenghea DT
J Diabetes Complications; 2015; 29(8):1119-23. PubMed ID: 26387808
[TBL] [Abstract][Full Text] [Related]
51. The ability of NT-proBNP to detect chronic heart failure and predict all-cause mortality is higher in elderly Chinese coronary artery disease patients with chronic kidney disease.
Fu S; Luo L; Ye P; Yi S; Liu Y; Zhu B; Wang L; Xiao T; Bai Y
Clin Interv Aging; 2013; 8():409-17. PubMed ID: 23723693
[TBL] [Abstract][Full Text] [Related]
52. Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types.
Doğan A; Gedikli O; Ozaydin M; Acar G
Anadolu Kardiyol Derg; 2010 Aug; 10(4):317-22. PubMed ID: 20693126
[TBL] [Abstract][Full Text] [Related]
53. Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.
Greene SJ; Fonarow GC; Solomon SD; Subacius HP; Ambrosy AP; Vaduganathan M; Maggioni AP; Böhm M; Lewis EF; Zannad F; Butler J; Gheorghiade M;
Eur J Heart Fail; 2017 Apr; 19(4):552-562. PubMed ID: 27748006
[TBL] [Abstract][Full Text] [Related]
54. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.
Tsutamoto T; Sakai H; Nishiyama K; Tanaka T; Fujii M; Yamamoto T; Horie M
Circ J; 2007 Dec; 71(12):1873-8. PubMed ID: 18037739
[TBL] [Abstract][Full Text] [Related]
55. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE
Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192
[TBL] [Abstract][Full Text] [Related]
56. Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study.
Kumarathurai P; Mouridsen MR; Mattsson N; Larsen BS; Nielsen OW; Gerds TA; Sajadieh A
Europace; 2017 Mar; 19(3):364-370. PubMed ID: 27194537
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.
Carlsen CM; Bay M; Kirk V; Gøtze JP; Køber L; Nielsen OW
Eur J Heart Fail; 2012 Mar; 14(3):240-7. PubMed ID: 22315457
[TBL] [Abstract][Full Text] [Related]
58. NT-proBNP, IGF-I and survival in patients with chronic heart failure.
Petretta M; Colao A; Sardu C; Scopacasa F; Marzullo P; Pivonello R; Fontanella L; de Caterina M; de Simone A; Bonaduce D
Growth Horm IGF Res; 2007 Aug; 17(4):288-96. PubMed ID: 17383209
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure.
Hamatani Y; Iguchi M; Ueno K; Aono Y; Esato M; Tsuji H; Wada H; Hasegawa K; Ogawa H; Abe M; Morita S; Akao M
Heart; 2021 May; 107(9):705-712. PubMed ID: 33219109
[TBL] [Abstract][Full Text] [Related]
60. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
